Clinical Trial: A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Advanced Malignant Neoplasm
Study Type: INTERVENTIONAL
Official Title: A Phase I Study to Evaluate the Safety, Tolerance and Pharmacokinetics of TQB3006 Tablets in Patients With Advanced Malignant Cancer
Brief Summary:
This study includes two stage: dose escalation and dose extension, with a single dose and a multiple dose study.This is a single-center, open, non-randomized, single arm, study to evaluate the safety, tolerability and pharmacokinetics of TQB3006 tables in patients with advanced malignant cancer.
Read more